
Silvia
Pérez Silanes
Catedrática de Universidad
Publications (83) Silvia Pérez Silanes publications
2024
-
Flavonoid-Quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis
ChemMedChem, Vol. 19, Núm. 18
-
Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease
International Journal of Molecular Sciences, Vol. 25, Núm. 2
-
Promising aryl selenoate derivatives as antileishmanial agents and their effects on gene expression
Antimicrobial Agents and Chemotherapy, Vol. 68, Núm. 4
-
Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (S, Se) and Their Azole Derivatives against Chagas Disease
Journal of Medicinal Chemistry, Vol. 67, Núm. 21, pp. 19038-19056
2023
2022
-
Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease
Bioorganic and Medicinal Chemistry, Vol. 58
-
Potential of sulfur-selenium isosteric replacement as a strategy for the development of new anti-chagasic drugs
Acta Tropica, Vol. 233
2021
-
Design and synthesis of Mannich base-type derivatives containing imidazole and benzimidazole as lead compounds for drug discovery in Chagas Disease
European Journal of Medicinal Chemistry, Vol. 223
2020
-
Selenium as an interesting option for the treatment of Chagas disease: A review
European Journal of Medicinal Chemistry, Vol. 206
-
The role of imidazole and benzimidazole heterocycles in Chagas disease: A review
European Journal of Medicinal Chemistry, Vol. 206
2019
-
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives
European Journal of Medicinal Chemistry, Vol. 163, pp. 569-582
-
Antichagasic profile of a Series of Mannich Base-Type Derivatives: Design, Synthesis, in vitro Evaluation, and Computational Studies Involving Iron Superoxide Dismutase
ChemistrySelect, Vol. 4, Núm. 27, pp. 8112-8121
-
Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation
Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 17, pp. 3902-3917
2018
-
Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases
European Journal of Medicinal Chemistry, Vol. 155, pp. 459-482
-
Second Generation of Mannich Base-Type Derivatives with in Vivo Activity against Trypanosoma cruzi
Journal of Medicinal Chemistry, Vol. 61, Núm. 13, pp. 5643-5663
2017
-
A Comparative Study of Conventional and Microwave-Assisted Synthesis of Quinoxaline 1,4-di-N-oxide N-acylhydrazones Derivatives Designed as Antitubercular Drug Candidates
Journal of Heterocyclic Chemistry, Vol. 54, Núm. 4, pp. 2380-2388
-
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity
Journal of Medicinal Chemistry, Vol. 60, Núm. 20, pp. 8647-8660
-
Development, validation and application of a GC–MS method for the simultaneous detection and quantification of neutral lipid species in Trypanosoma cruzi
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1061-1062, pp. 225-232
-
In vitro antileishmanial activity and iron superoxide dismutase inhibition of arylamine Mannich base derivatives
Parasitology, Vol. 114, Núm. 13, pp. 1783-1790
-
Library of seleno-compounds as novel agents against Leishmania species
Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 6